Industry

Seasoned drug discovery leader will join Valo to further advance human-centric, AI-enabled drug discovery LEXINGTON, Mass.–(BUSINESS WIRE)–#DrugDiscovery—Valo Health, Inc. (“Valo”), a company pioneering the use of human data and AI to accelerate drug discovery and development, today announced the appointment of Karin Conde-Knape, Ph.D., as Chief Scientific Officer (CSO). Dr. Conde-Knape brings more than two … [Read more…]

PARIS & PALO ALTO, Calif.–(BUSINESS WIRE)–LBO France, a multi-specialist investment platform and pioneer in private equity, announced today the signing of a definitive agreement with Vivo Capital, a leading global investment firm focused exclusively on healthcare and life sciences, for the sale of Dutscher Group (‘Dutscher’ or ‘the Group’), the European leader in consumables and … [Read more…]

WASHINGTON–(BUSINESS WIRE)–By virtue of its exclusive contract to manage the 340B Drug Pricing Program since 2004, Apexus has become a government-sanctioned entity fraught with self-dealing interests in the 340B marketplace. AIDS Healthcare Foundation (AHF) welcomes Senator Bill Cassidy’s (R-LA) inquiry into Apexus. The prime vendor is a wolf in sheep’s clothing, leveraging its former nonprofit … [Read more…]

An All-New Docuseries from Executive Producers Jeannie Mai, Alyssa Milano, and Award-Winning Filmmakers Sadhvi Siddhali Shree and Sadhvi Anubhuti NEW YORK–(BUSINESS WIRE)–Tellory sponsored a luncheon in celebration of the premiere of Balance: A Perimenopause Journey, a new docuseries produced by Jeannie Mai and Alyssa Milano that explores the often misunderstood and under-discussed realities of perimenopause. … [Read more…]

CHICAGO–(BUSINESS WIRE)–Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today announced that its Board of Directors (the “Board”) has approved an amendment to extend the Company’s existing Stockholder Rights Plan to December 31, 2026 (the “Rights Plan”). The Board’s decision to extend the Rights Plan is based on … [Read more…]

Susan G. Komen® Applauds Bill Introduction, Urges Quick Passage HONOLULU–(BUSINESS WIRE)–Susan G. Komen®, the world’s leading breast cancer organization commends Representative Lauren Matsuomto (R-Mililani) introducing legislation to ensure equitable access to required diagnostic and supplemental breast imaging, by eliminating the financial barriers patients face in accessing needed breast cancer screening. The exorbitant out-of-pocket costs associated … [Read more…]

Deal enhances existing value, evidence, and market access solutions as demand for economic and outcomes services accelerates YARDLEY, Pa.–(BUSINESS WIRE)–Red Nucleus, a leading provider of strategic services across research and development, medical affairs, market access, commercial, and learning & development, today announced that it has acquired Bridge Medical Consulting, a specialized health economics and outcomes … [Read more…]

Search Committee Has Initiated a Global Search to Select Next CEO LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that its Board of Directors (the “Board”) has appointed Warren Foust, … [Read more…]

Service ensures that clinicians are properly qualified, consistently trained and monitored throughout the life of a trial MAIDENHEAD, England–(BUSINESS WIRE)–RWS (RWS.L), a global AI solutions company, announces the launch of a new rater training, certification and retraining service designed specifically to improve data quality, consistency and reliability in central nervous system (CNS) clinical trials. The … [Read more…]

The United States (U.S.) Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) resubmission for RelabotulinumtoxinA for the temporary improvement of moderate-to-severe glabellar lines (frown lines) and lateral canthal lines (crow’s feet) in adults RelabotulinumtoxinA is designed to optimize molecule integrity to deliver fast onset of action as early as Day 1 … [Read more…]